Therapeutic Resistance to Anti-hormonal Drugs in Breast Cancer New Molecular Aspects and their Potential as Targets /

Therapeutic Resistance to Anti-hormonal Drugs in Breast Cancer New Molecular Aspects and their Potential as Targets /

Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Hiscox, Stephen. (Editor), Gee, Julia. (Editor), Nicholson, Robert I. (Editor)
Format: eBook
Language:English
Published: Dordrecht : Springer Netherlands : Imprint: Springer, 2009.
Edition:1st ed. 2009.
Subjects:
Cancer research.
Oncology  .
Cancer Research.
Oncology.
Online Access:https://doi.org/10.1007/978-1-4020-8526-0
LEADER 02017nam a22003255i 4500
001 978-1-4020-8526-0
005 20191026081615.0
007 cr nn 008mamaa
008 100301s2009 ne | s |||| 0|eng d
020 |a 9781402085260 
024 7 |a 10.1007/978-1-4020-8526-0  |2 doi 
040 |a Sistema de Bibliotecas del Tecnológico de Costa Rica 
245 1 0 |a Therapeutic Resistance to Anti-hormonal Drugs in Breast Cancer  |b New Molecular Aspects and their Potential as Targets /  |c edited by Stephen Hiscox, Julia Gee, Robert I. Nicholson. 
250 |a 1st ed. 2009. 
260 # # |a Dordrecht :  |b Springer Netherlands :  |b Imprint: Springer,  |c 2009. 
300 |a XII, 204 p.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
505 0 |a Experimental Endocrine Resistance: Concepts and Strategies -- Transcriptional Coactivators and Corepressors in Endocrine Response and Resistance in Breast Cancer -- The Re-Expression of Estrogen Receptor in Estrogen Receptor-Negative Breast Cancer and Restoration of Anti-Estrogen Responses -- The Dark Side of Antihormonal Action in Breast Cancer -- Influence of the Tumour Microenvironment -- Are Stem-Like Cells Responsible for Resistance to Therapy in Breast Cancer? -- HSP90 Inhibition as an Anticancer Strategy: Novel Approaches and Future Directions -- Adverse Features of Acquired Antihormone Resistance and Their Targeting -- Identifying Modifiers of Tamoxifen Sensitivity Using High-Throughput Genetic and Chemical Screens -- Endocrine Resistance in Breast Cancer- Where Are We NowWith Intelligent Combination Therapies?. 
650 0 |a Cancer research. 
650 0 |a Oncology  . 
650 1 4 |a Cancer Research. 
650 2 4 |a Oncology. 
700 1 |a Hiscox, Stephen.  |e editor. 
700 1 |a Gee, Julia.  |e editor. 
700 1 |a Nicholson, Robert I.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
856 4 0 |u https://doi.org/10.1007/978-1-4020-8526-0 

Similar Items